Drug Profile
Ingenol triacetate
Latest Information Update: 14 Sep 1998
Price :
$50
*
At a glance
- Originator Rational Drug Design Laboratories
- Class Antivirals; Ingenols
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 14 Sep 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 19 Sep 1996 New profile
- 19 Sep 1996 Preclinical development for HIV infections treatment in Japan (Unknown route)